Oroxylin a prevents inflammation-related tumor through down-regulation of inflammatory gene expression by inhibiting NF-κB signaling

Molecular Carcinogenesis

Volumn 53, Issue 2, 2014, Pages 145-158

  Yao, Jing ^a   Hu, Rong ^a   Sun, Jie ^a   Lin, Biqi ^a   Zhao, Li ^a   Sha, Yunying ^a   Zhu, Binbin ^a   You, Qi Dong ^a   Yan, Tianhua ^a   Guo, Qing Long ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Chemoprevention; Inflammatory cytokines; NF B; Oroxylin A

Indexed keywords

I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OROXYLIN A; PYRROLIDINE DITHIOCARBAMATE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR RELA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CELL VIABILITY; CHEMOPROPHYLAXIS; COLON CARCINOMA; CONFOCAL MICROSCOPY; CYTOKINE RELEASE; DOWN REGULATION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UBIQUITINATION; WESTERN BLOTTING;

CHEMOPREVENTION; INFLAMMATORY CYTOKINES; NF-ΚB; OROXYLIN A;

CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; FLAVONOIDS; GENE EXPRESSION; HCT116 CELLS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; NF-KAPPA B; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84892897904     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.21958     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
2. Li Q, Withoff S, Verma IM. Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 2005; 26:318-325.
3. Karin M, Greten FR. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5:749-759.
4. Bissell MJ, Radisky DC, Rizki A, et al. The organizing principle: Microenvironmental influences in the normal and malignant breast. Differentiation 2002; 70:537-546.
5. De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007; 7:256-269.
6. Schoppmann SF, Birner P, Stockl J, et al. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol 2002; 161:947-956.
7. Schottelius AJ, Dinter H. Cytokines, NF-kappaB, microenvironment, intestinal inflammation and cancer. Cancer Treat Res 2006; 130:67-87.
8. Schwartsburd PM. Chronic inflammation as inductor of pro-cancer microenvironment: Pathogenesis of dysregulated feedback control. Cancer Metastasis Rev 2003; 22:95-102.
9. Keibel A, Singh V, Sharma MC. Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des 2009; 15:1949-1955.
10. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-867.
11. Sica A, Allavena P, Mantovani A. Cancer related inflammation: The macrophage connection. Cancer Lett 2008; 267:204-215.
12. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441:431-436.
13. Wong CP, Bray TM, Ho E. Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages. Cancer Lett 2009; 276:38-46.
14. Karin M, Cao Y, Greten FR, et al. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2002; 2:301-310.
15. Hatada EN, Nieters A, Wulczyn FG, et al. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. Proc Natl Acad Sci USA 1992; 89:2489-2493.
16. Malek S, Huxford T, Ghosh G. Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. J Biol Chem 1998; 273:25427-25435.
17. Karin M, Delhase M. The I kappa B kinase (IKK) and NF-kappa B: Key elements of proinflammatory signalling. Semin Immunol 2000; 12:85-98.
18. Baeuerle PA, Baltimore D. NF-kappa B: Ten years after. Cell 1996; 87:13-20.
19. Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001; 357:539-545.
20. Kandaswami C, Lee LT, Lee PP, et al. The antitumor activities of flavonoids. In Vivo 2005; 19:895-909.
21. Ren W, Qiao Z, Wang H, et al. Flavonoids: Promising anticancer agents. Med Res Rev 2003; 23:519-534.
22. Lee WR, Shen SC, Lin HY, et al. Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem Pharmacol 2002; 63:225-236.
23. Kanno S, Tomizawa A, Ohtake T, et al. Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett 2006; 166:131-139.
24. Banerjee S, Zhang Y, Ali S, et al. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res 2005; 65:9064-9072.
25. Mohammad RM, Banerjee S, Li Y, et al. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer 2006; 106:1260-1268.
26. Hu Y, Yang Y, You QD, et al. Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. Biochem Biophys Res Commun 2006; 351:521-527.
27. Li HN, Nie FF, Liu W, et al. Apoptosis induction of oroxylin A in human cervical cancer HeLa cell line in vitro and in vivo. Toxicology 2009; 257:80-85.
28. Yang Y, Hu Y, Gu HY, et al. Oroxylin A induces G2/M phase cell-cycle arrest via inhibiting Cdk7-mediated expression of Cdc2/p34 in human gastric carcinoma BGC-823 cells. J Pharm Pharmacol 2008; 60:1459-1463.
29. Li HB, Chen F. Isolation and purification of baicalein, wogonin and oroxylin A from the medicinal plant Scutellaria baicalensis by high-speed counter-current chromatography. J Chromatogr 2005; 1074:107-110.
30. Gao Y, Lu N, Ling Y, et al. Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation. J Cancer Res Clin Oncol 2010; 136:667-675.
31. Schmidt J, Ryschich E, Sievers E, et al. Telomerase-specific T-cells kill pancreatic tumor cells in vitro and in vivo. Cancer 2006; 106:759-764.
32. Qiang L, Yang Y, You QD, et al. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study. Biochem Pharmacol 2008; 75:1083-1092.
33. Andre F, Berrada N, Desmedt C. Implication of tumor microenvironment in the resistance to chemotherapy in breast cancer patients. Curr Opin Oncol 2010; 22:547-551.
34. Erez N, Truitt M, Olson P, et al. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010; 17:135-147.
35. Goodman JE, Hofseth LJ, Hussain SP, et al. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ Mol Mutagen 2004; 44:3-9.
36. Chi YS, Lim H, Park H, et al. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: In vivo regulation of inflammation-associated gene expression. Biochem pharmacol 2003; 66:1271-1278.
37. Middleton E, Jr., Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52:673-751.
38. Chen YC, Shen SC, Chen LG, et al. Wogonin, baicalin, and baicalein inhibition of inducible nitric oxide synthase and cyclooxygenase-2 gene expressions induced by nitric oxide synthase inhibitors and lipopolysaccharide. Biochem Pharmacol 2001; 61:1417-1427.
39. Ma Z, Otsuyama K, Liu S, et al. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood 2005; 105:3312-3318.
40. Fas SC, Baumann S, Zhu JY, et al. Wogonin sensitizes resistant malignant cells to TNFalpha- and TRAIL-induced apoptosis. Blood 2006; 108:3700-3706.
41. Chen Y, Yang L, Lee TJ. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation. Biochem Pharmacol 2000; 59:1445-1457.
42. Dann SM, Spehlmann ME, Hammond DC, et al. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol 2008; 180:6816-6826.
43. Beutler B, Rietschel ET. Innate immune sensing and its roots: The story of endotoxin. Nat Rev Immunol 2003; 3:169-176.
44. Fenton MJ, Clark BD, Collins KL, et al. Transcriptional regulation of the human prointerleukin 1 beta gene. J Immunol 1987; 138:3972-3979.
45. Sung SS, Walters JA. Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes. J Clin Invest 1991; 88:1915-1923.